In the IMvigor011 trial, ctDNA-guided adjuvant atezolizumab reduced the risk of disease recurrence or death by 36% and the ...
Patients treated with benralizumab showed significant improvements in fatigue scores and experienced fewer flares requiring an increase in oral corticosteroid use.
There is no evidence of an association between first-trimester exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) and major congenital malformations (MCM ...
Peanut oral immunotherapy safe for young children aged 1 to 3 years with slow up-dosing and low maintenance dosing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results